ANI Pharmaceuticals Sets New Records as Rare Disease Revenue Soars 84% in 2025 and 2026 Outlook Tops $1 Billion
Market Chameleon (Fri, 27-Feb 9:21 AM)
ANI Pharmaceuticals Projects Rare Disease Revenues to Exceed $600 Million in 2026, Marking a Major Strategic Shift
Market Chameleon (Mon, 12-Jan 7:53 AM)
